Cargando…

Neutralization and Stability of SARS-CoV-2 Omicron Variant

The SARS-CoV-2 B.1.1.529/Omicron variant was first characterized in South Africa and was swiftly designated a variant of concern(1). Of great concern is its high number of mutations, including 30–40 mutations in the virus spike (S) protein compared to 7–10 for other variants. Some of these mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Cong, Evans, John P., Qu, Panke, Faraone, Julia, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Zhou, Tongqing, Lozanski, Gerard, Mallampalli, Rama, Saif, Linda J., Oltz, Eugene M., Mohler, Peter, Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722590/
https://www.ncbi.nlm.nih.gov/pubmed/34981053
http://dx.doi.org/10.1101/2021.12.16.472934
_version_ 1784625544449490944
author Zeng, Cong
Evans, John P.
Qu, Panke
Faraone, Julia
Zheng, Yi-Min
Carlin, Claire
Bednash, Joseph S.
Zhou, Tongqing
Lozanski, Gerard
Mallampalli, Rama
Saif, Linda J.
Oltz, Eugene M.
Mohler, Peter
Xu, Kai
Gumina, Richard J.
Liu, Shan-Lu
author_facet Zeng, Cong
Evans, John P.
Qu, Panke
Faraone, Julia
Zheng, Yi-Min
Carlin, Claire
Bednash, Joseph S.
Zhou, Tongqing
Lozanski, Gerard
Mallampalli, Rama
Saif, Linda J.
Oltz, Eugene M.
Mohler, Peter
Xu, Kai
Gumina, Richard J.
Liu, Shan-Lu
author_sort Zeng, Cong
collection PubMed
description The SARS-CoV-2 B.1.1.529/Omicron variant was first characterized in South Africa and was swiftly designated a variant of concern(1). Of great concern is its high number of mutations, including 30–40 mutations in the virus spike (S) protein compared to 7–10 for other variants. Some of these mutations have been shown to enhance escape from vaccine-induced immunity, while others remain uncharacterized. Additionally, reports of increasing frequencies of the Omicron variant may indicate a higher rate of transmission compared to other variants. However, the transmissibility of Omicron and its degree of resistance to vaccine-induced immunity remain unclear. Here we show that Omicron exhibits significant immune evasion compared to other variants, but antibody neutralization is largely restored by mRNA vaccine booster doses. Additionally, the Omicron spike exhibits reduced receptor binding, cell-cell fusion, S1 subunit shedding, but increased cell-to-cell transmission, and homology modeling indicates a more stable closed S structure. These findings suggest dual immune evasion strategies for Omicron, due to altered epitopes and reduced exposure of the S receptor binding domain, coupled with enhanced transmissibility due to enhanced S protein stability. These results highlight the importance of booster vaccine doses for maintaining protection against the Omicron variant, and provide mechanistic insight into the altered functionality of the Omicron spike protein.
format Online
Article
Text
id pubmed-8722590
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-87225902022-01-04 Neutralization and Stability of SARS-CoV-2 Omicron Variant Zeng, Cong Evans, John P. Qu, Panke Faraone, Julia Zheng, Yi-Min Carlin, Claire Bednash, Joseph S. Zhou, Tongqing Lozanski, Gerard Mallampalli, Rama Saif, Linda J. Oltz, Eugene M. Mohler, Peter Xu, Kai Gumina, Richard J. Liu, Shan-Lu bioRxiv Article The SARS-CoV-2 B.1.1.529/Omicron variant was first characterized in South Africa and was swiftly designated a variant of concern(1). Of great concern is its high number of mutations, including 30–40 mutations in the virus spike (S) protein compared to 7–10 for other variants. Some of these mutations have been shown to enhance escape from vaccine-induced immunity, while others remain uncharacterized. Additionally, reports of increasing frequencies of the Omicron variant may indicate a higher rate of transmission compared to other variants. However, the transmissibility of Omicron and its degree of resistance to vaccine-induced immunity remain unclear. Here we show that Omicron exhibits significant immune evasion compared to other variants, but antibody neutralization is largely restored by mRNA vaccine booster doses. Additionally, the Omicron spike exhibits reduced receptor binding, cell-cell fusion, S1 subunit shedding, but increased cell-to-cell transmission, and homology modeling indicates a more stable closed S structure. These findings suggest dual immune evasion strategies for Omicron, due to altered epitopes and reduced exposure of the S receptor binding domain, coupled with enhanced transmissibility due to enhanced S protein stability. These results highlight the importance of booster vaccine doses for maintaining protection against the Omicron variant, and provide mechanistic insight into the altered functionality of the Omicron spike protein. Cold Spring Harbor Laboratory 2021-12-20 /pmc/articles/PMC8722590/ /pubmed/34981053 http://dx.doi.org/10.1101/2021.12.16.472934 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Zeng, Cong
Evans, John P.
Qu, Panke
Faraone, Julia
Zheng, Yi-Min
Carlin, Claire
Bednash, Joseph S.
Zhou, Tongqing
Lozanski, Gerard
Mallampalli, Rama
Saif, Linda J.
Oltz, Eugene M.
Mohler, Peter
Xu, Kai
Gumina, Richard J.
Liu, Shan-Lu
Neutralization and Stability of SARS-CoV-2 Omicron Variant
title Neutralization and Stability of SARS-CoV-2 Omicron Variant
title_full Neutralization and Stability of SARS-CoV-2 Omicron Variant
title_fullStr Neutralization and Stability of SARS-CoV-2 Omicron Variant
title_full_unstemmed Neutralization and Stability of SARS-CoV-2 Omicron Variant
title_short Neutralization and Stability of SARS-CoV-2 Omicron Variant
title_sort neutralization and stability of sars-cov-2 omicron variant
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722590/
https://www.ncbi.nlm.nih.gov/pubmed/34981053
http://dx.doi.org/10.1101/2021.12.16.472934
work_keys_str_mv AT zengcong neutralizationandstabilityofsarscov2omicronvariant
AT evansjohnp neutralizationandstabilityofsarscov2omicronvariant
AT qupanke neutralizationandstabilityofsarscov2omicronvariant
AT faraonejulia neutralizationandstabilityofsarscov2omicronvariant
AT zhengyimin neutralizationandstabilityofsarscov2omicronvariant
AT carlinclaire neutralizationandstabilityofsarscov2omicronvariant
AT bednashjosephs neutralizationandstabilityofsarscov2omicronvariant
AT zhoutongqing neutralizationandstabilityofsarscov2omicronvariant
AT lozanskigerard neutralizationandstabilityofsarscov2omicronvariant
AT mallampallirama neutralizationandstabilityofsarscov2omicronvariant
AT saiflindaj neutralizationandstabilityofsarscov2omicronvariant
AT oltzeugenem neutralizationandstabilityofsarscov2omicronvariant
AT mohlerpeter neutralizationandstabilityofsarscov2omicronvariant
AT xukai neutralizationandstabilityofsarscov2omicronvariant
AT guminarichardj neutralizationandstabilityofsarscov2omicronvariant
AT liushanlu neutralizationandstabilityofsarscov2omicronvariant